Nabriva Therapeutics plc Annual Weighted Average Number of Shares Outstanding, Basic from 2014 to 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nabriva Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2014 to 2022.
  • Nabriva Therapeutics plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 3.23M shares, a 27.7% increase year-over-year.
  • Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.68M shares, a 54.7% increase from 2021.
  • Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.73M shares, a 237% increase from 2020.
  • Nabriva Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 514K shares, a 93.1% decline from 2019.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 2.68M +948K +54.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 1.73M +1.22M +237% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 514K -6.91M -93.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-04-17
2019 7.42M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2016 2.15M +1.09M +103% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-24
2015 1.06M +734K +226% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-24
2014 325K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.